Sarepta Rebounded. Its Gene Therapy Is Back on Course. -- Barrons.com
Sarepta Rebounded. Its Gene Therapy Is Back on Course. -- Barrons.com
萨雷普塔反弹。它的基因疗法又回到了正轨。— Barrons.com
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册